TMPRSS2 and prostate intraepithelial neoplasia: Homogeneous distribution of TMPRSS2-ERG fusion in 19% of high-grade prostatic intraepithelial neoplasia (PIN) lesions and in 50% of localized PCa suggests this fusion as either occurring after onset or associated with early events predisposing to clinical progression [38].